CD26 has a cleavage activity against diverse substrates such as chemokines, such as disruption of the SDF1-CXCR4 axis leading to the release of CML LSCs into the PB [16]. The gene discussed is CXCR4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.